Enterprise record

Voyager Therapeutics, Inc.

Public governance Claims and source records for this enterprise.

Alpha ID: alpha:company:5418ad49-db81-48f1-8181-8dfe06436feeVersion: public-1As of: unavailable

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Identity

unclaimed

Evidence

source reported

Evaluation

Unknown

Monitoring

Unknown

Authority

Unknown

Freshness

Observed 2026-09-27

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 27, 2026

    Supports 3 claims
    • Legal Name: Voyager Therapeutics, Inc. · Claim reviewed: Sep 27, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 27, 2026
    • Published Fact: US · Claim reviewed: Sep 27, 2026

  2. DEF 14A vygr-20250603xdef14a.htm

    sec proxy · Source published: Apr 23, 2025 · Retrieved: Sep 2, 2026

    Supports 10 claims
    • Leadership Role: Alfred Sandrock: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Catherine J. Mackey: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: George Scangos: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Glenn Pierce: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Grace E. Colón: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: James A. Geraghty: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Jude Onyia: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Michael Higgins: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Nancy Vitale: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Steven Hyman: Director · Claim reviewed: Sep 27, 2026